Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   


OLIENA
Language recovery after stroke
App | Video | PDF (278 pp) | Web

  Hepatitis

  Free Subscription


Articles published in J Interferon Cytokine Res

Retrieve available abstracts of 17 articles:
HTML format
Text format



Single Articles


    August 2018
  1. ABD EL-MEGUID M, Dawood RM, Mokhles MA, El Awady MK, et al
    Extrahepatic Upregulation of Transforming Growth Factor Beta 2 in HCV Genotype 4-Induced Liver Fibrosis.
    J Interferon Cytokine Res. 2018;38:341-347.
    PubMed     Text format     Abstract available


    July 2018
  2. COOKSLEY H, Riva A, Katzarov K, Hadzhiolova-Lebeau T, et al
    Differential Expression of Immune Inhibitory Checkpoint Signatures on Antiviral and Inflammatory T Cell Populations in Chronic Hepatitis B.
    J Interferon Cytokine Res. 2018;38:273-282.
    PubMed     Text format     Abstract available


    June 2018
  3. NAZ Z, Wahid B, Usman S, Saleem K, et al
    Expression of SOCS1 and SOCS3 Genes in Interferon-Treated and Direct-Acting Antiviral Drugs-Treated Hepatitis C Patients.
    J Interferon Cytokine Res. 2018;38:255-260.
    PubMed     Text format     Abstract available


    May 2018
  4. CAO WH, Li MH, Pan CQ, Lu Y, et al
    Quantitation of Plasmacytoid Dendritic Cells in Chronic Hepatitis B Patients with HBeAg Positivity During PEG-IFN and Entecavir Therapy.
    J Interferon Cytokine Res. 2018;38:197-205.
    PubMed     Text format     Abstract available


    March 2018
  5. EL-RAZIKY M, Khairy M, Fouad A, Salama A, et al
    Effect of Direct-Acting Agents on Fibrosis Regression in Chronic Hepatitis C Virus Patients' Treatment Compared with Interferon-Containing Regimens.
    J Interferon Cytokine Res. 2018;38:129-136.
    PubMed     Text format     Abstract available


  6. WAHID B, Rafique S, Saleem K, Ali A, et al
    An Increase in Expression of SOCS1 Gene with Increase in Hepatitis C Virus Viral Load.
    J Interferon Cytokine Res. 2018;38:122-128.
    PubMed     Text format     Abstract available


    February 2018
  7. ZAREBSKA-MICHALUK D, Flisiak R, Jaroszewicz J, Janczewska E, et al
    Is Interferon-Based Treatment of Viral Hepatitis C Genotype 3 Infection Still of Value in the Era of Direct-Acting Antivirals?
    J Interferon Cytokine Res. 2018;38:93-100.
    PubMed     Text format     Abstract available


    January 2018
  8. EL KASSAS M, Omran D, Elsaeed K, Alboraie M, et al
    Spur-of-the-Moment Modification in National Treatment Policies Leads to a Surprising HCV Viral Suppression in All Treated Patients: Real-Life Egyptian Experience.
    J Interferon Cytokine Res. 2018 Jan 22. doi: 10.1089/jir.2017.0121.
    PubMed     Text format     Abstract available


  9. ALEZZI ZMM, Abd El Rehim AY, Fathallah WF, Alamrani MA, et al
    Factors Affecting the Virological Response Among Chronic Hepatitis C Virus Patients in Yemen.
    J Interferon Cytokine Res. 2018;38:38-44.
    PubMed     Text format     Abstract available


    November 2017
  10. ALTRAIF IH, Sanai F, Babatin MA, Alalwan AA, et al
    Pharmacokinetics-Based Adjusted Versus Standard Dose of Ribavirin Does Not Improve Virologic Response Rates in Chronic Hepatitis C Genotype 4 Patients: A Randomized Controlled Trial.
    J Interferon Cytokine Res. 2017;37:488-493.
    PubMed     Text format     Abstract available


    July 2017
  11. JI F, Zhou R, Wang W, Bai D, et al
    High Post-treatment alpha-Fetoprotein Levels and Aspartate Aminotransferase-to-Platelet Ratio Index Predict Hepatocellular Carcinoma in Hepatitis C Virus Decompensated Cirrhotic Patients with Sustained Virological Response After Antiviral Therapy.
    J Interferon Cytokine Res. 2017 Jul 21. doi: 10.1089/jir.2017.0040.
    PubMed     Text format     Abstract available


  12. BHUSHAN A, Ghosh S, Bhattacharjee S, Chinnaswamy S, et al
    Confounding by Single Nucleotide Polymorphism rs117648444 (P70S) Affects the Association of Interferon Lambda Locus Variants with Response to Interferon-alpha-Ribavirin Therapy in Patients with Chronic Genotype 3 Hepatitis C Virus Infection.
    J Interferon Cytokine Res. 2017 Jul 20. doi: 10.1089/jir.2017.0002.
    PubMed     Text format     Abstract available


    June 2017
  13. EL-MESERY M, El-Mowafy M, Elgaml A, Youssef LF, et al
    Correlation of Serum Soluble Fibrinogen-Like Protein 2 with Soluble FAS Ligand and Interferon Gamma in Egyptian Hepatitis C Virus-Infected Patients and Hepatocellular Carcinoma Patients.
    J Interferon Cytokine Res. 2017 Jun 13. doi: 10.1089/jir.2016.0128.
    PubMed     Text format     Abstract available


    May 2017
  14. SALUM GM, Bader El Din NG, Ibrahim MK, Anany MM, et al
    Vascular Endothelial Growth Factor Expression in Hepatitis C Virus-Induced Liver Fibrosis: A Potential Biomarker.
    J Interferon Cytokine Res. 2017 May 4. doi: 10.1089/jir.2016.0127.
    PubMed     Text format     Abstract available


    April 2017
  15. BENITO JM, Garcia-Samaniego J, Garcia M, Madejon A, et al
    Both Hepatitis C Virus-Specific T Cell Responses and IL28B rs12979860 Single-Nucleotide Polymorphism Genotype Influence Antihepatitis C Virus Treatment Outcome in Patients with Chronic Hepatitis C.
    J Interferon Cytokine Res. 2017 Apr 25. doi: 10.1089/jir.2016.0078.
    PubMed     Text format     Abstract available


  16. HSIAO JL, Ko WS, Shih CJ, Chiou YL, et al
    The Changed Proportion of CD45RA+/CD45RO+ T Cells in Chronic Hepatitis C Patients During Pegylated Interferon-alpha with Ribavirin Therapy.
    J Interferon Cytokine Res. 2017 Apr 17. doi: 10.1089/jir.2016.0113.
    PubMed     Text format     Abstract available


  17. SHENEEF A, Esmat MM, Mohammad AN, Mahmoud AA, et al
    Interleukin-10 and Interferon Gamma Gene Polymorphisms and Hepatitis C Virus-Related Liver Cirrhosis Risk.
    J Interferon Cytokine Res. 2017;37:175-180.
    PubMed     Text format     Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Hepatitis is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: